Medical Therapy in Chronic Refractory Ulcerative Colitis: When Enough Is Enough

Area of Science:

• Gastroenterology and Hepatology
• Inflammatory Bowel Disease Research
• Surgical Gastroenterology

Background:

• Ulcerative colitis (UC) management has improved with biologics and small molecules.
• A subset of UC patients remains refractory to medical treatment, necessitating colectomy.
• The concept of irreversible bowel damage and optimal surgical timing in UC is underexplored.

Purpose of the Study:

• To discuss the concept of disease progression in ulcerative colitis.
• To explore the limitations of current medical treatments for refractory UC.
• To propose a three-step algorithm for timely surgical indication in clinical practice.

Main Methods:

• Literature review on ulcerative colitis disease progression.
• Analysis of treatment outcomes in medically refractory UC patients.
• Development of a clinical algorithm for surgical decision-making.

Main Results:

• Medical advancements have decreased but not eliminated colectomy rates in UC.
• Refractory UC patients face risks of complications due to delayed surgery, including cancer.
• The proposed algorithm aims to optimize surgical timing and prevent disease progression.

Conclusions:

• Timely surgical intervention is crucial for refractory ulcerative colitis patients to prevent irreversible damage and complications.
• An evidence-based algorithm can guide clinicians in identifying optimal surgical timing.
• Further research is needed to fully understand and mitigate disease progression in UC.